D.A. Davidson & Co. Abbott Laboratories Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Abbott Laboratories stock. As of the latest transaction made, D.A. Davidson & Co. holds 160,064 shares of ABT stock, worth $18 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

160,064

Previous 165,350 3.2%

Holding current value

$18 Million

Previous $18.8 Million 11.5%

% of portfolio

0.15%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $532,458 - $594,357	-5,286 Reduced 3.2%	160,064 $16.6 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $178,955 - $197,648	1,634 Added 1.0%	165,350 $18.8 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $392,957 - $481,012	-4,357 Reduced 2.59%	163,716 $18 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $92,664 - $111,181	970 Added 0.58%	168,073 $16.3 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $261,725 - $291,617	2,597 Added 1.58%	167,103 $18.2 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $129,017 - $151,861	1,332 Added 0.82%	164,506 $16.7 Million
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $67,017 - $78,621	-705 Reduced 0.43%	163,174 $17.9 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $10,159 - $11,763	-105 Reduced 0.06%	163,879 $15.9 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $82,370 - $99,559	807 Added 0.49%	163,984 $17.8 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $57,352 - $69,937	503 Added 0.31%	163,177 $19.3 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $126,158 - $154,474	1,092 Added 0.68%	162,674 $22.9 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.93 Million - $2.14 Million	16,582 Added 11.44%	161,582 $19.1 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $135,093 - $159,024	-1,277 Reduced 0.87%	145,000 $16.8 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $1.81 Million - $2.13 Million	16,614 Added 12.81%	146,277 $17.5 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $420,945 - $458,709	-4,009 Reduced 3.0%	129,663 $14.2 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $307,727 - $373,711	-3,358 Reduced 2.45%	133,672 $14.5 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $3 Million - $3.84 Million	-39,217 Reduced 22.25%	137,030 $12.5 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $455,319 - $665,801	-7,248 Reduced 3.95%	176,247 $13.9 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.25 Million - $1.39 Million	15,888 Added 9.48%	183,495 $15.9 Million
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $209,101 - $226,730	2,555 Added 1.55%	167,607 $14 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $1.21 Million - $1.41 Million	-16,556 Reduced 9.12%	165,052 $13.9 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $97,674 - $118,088	-1,475 Reduced 0.81%	181,608 $13.8 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $400,702 - $453,938	-6,112 Reduced 3.23%	183,083 $13.2 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $222,747 - $268,717	3,663 Added 1.97%	189,195 $13.9 Million
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $216,578 - $239,037	3,762 Added 2.07%	185,532 $11.3 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $220,015 - $248,754	3,910 Added 2.2%	181,770 $10.9 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $809,226 - $866,360	15,075 Added 9.26%	177,860 $10.2 Million
Q3 2017 Nov 08, 2017	SELL	$48.06 - $53.64 $741,709 - $827,826	-15,433 Reduced 8.66%	162,785 $8.69 Million
Q2 2017 Aug 11, 2017	BUY	N/A	178,218	178,218 $0

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account